Your browser doesn't support javascript.
loading
Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling.
Gottlieb, Sami L; Giersing, Birgitte; Boily, Marie-Claude; Chesson, Harrell; Looker, Katharine J; Schiffer, Joshua; Spicknall, Ian; Hutubessy, Raymond; Broutet, Nathalie.
Affiliation
  • Gottlieb SL; World Health Organization (WHO), Geneva, Switzerland. Electronic address: gottliebs@who.int.
  • Giersing B; World Health Organization (WHO), Geneva, Switzerland.
  • Boily MC; Imperial College, London, UK.
  • Chesson H; Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Looker KJ; University of Bristol, UK.
  • Schiffer J; University of Washington, Seattle, WA, USA.
  • Spicknall I; Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Hutubessy R; World Health Organization (WHO), Geneva, Switzerland.
  • Broutet N; World Health Organization (WHO), Geneva, Switzerland.
Vaccine ; 37(50): 7336-7345, 2019 11 28.
Article in En | MEDLINE | ID: mdl-28647165

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Herpesvirus 2, Human / Herpesvirus 1, Human / Herpes Simplex Virus Vaccines / Herpes Simplex Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Vaccine Year: 2019 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Herpesvirus 2, Human / Herpesvirus 1, Human / Herpes Simplex Virus Vaccines / Herpes Simplex Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Vaccine Year: 2019 Document type: Article Country of publication: Netherlands